Skip to Content
Merck
CN
  • Intermediate analogue inhibitors of mandelate racemase: N-Hydroxyformanilide and cupferron.

Intermediate analogue inhibitors of mandelate racemase: N-Hydroxyformanilide and cupferron.

Bioorganic & medicinal chemistry letters (2006-10-24)
Jennifer R Bourque, Rodney K M Burley, Stephen L Bearne
ABSTRACT

Mandelate racemase (MR) catalyzes the 1,1-proton transfer that interconverts the enantiomers of mandelate. The transition state/intermediate analogues N-hydroxyformanilide (K(i)=2.79+/-0.19 microM) and cupferron (K(i)=2.67+/-0.09 microM) are identified as potent competitive inhibitors of MR. The pH-pK(i) profile indicates that MR can bind either the protonated or deprotonated forms of N-hydroxyformanilide, with a 10-fold greater affinity for the latter form.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
(R)-(−)-Mandelic acid, 98%
Sigma-Aldrich
Benzhydroxamic acid, 99%
Sigma-Aldrich
(R)-(−)-Mandelic acid, ReagentPlus®, ≥99%
Sigma-Aldrich
Cupferron, 97%, reagent grade